* Paragon 28 Inc FNA.N reported a quarterly adjusted loss
of 23
cents per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -15
cents. The mean expectation of seven analysts for the quarter
was for a loss of 9 cents per share. Wall Street expected
results to range from -11 cents to -6 cents per share.
* Revenue rose 17.6% to $60.56 million from a year ago;
analysts
expected $60.46 million.
* Paragon 28 Inc's reported EPS for the quarter was a loss
of 23
cents.
* The company reported a quarterly loss of $19.56 million.
* Paragon 28 Inc shares had fallen by 2.3% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Paragon 28 Inc is
$17.50
This summary was machine generated from LSEG data February 29 at
10:00 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.09 -0.23 Missed
Sep. 30 2023 -0.10 -0.10 Met
Jun. 30 2023 -0.10 -0.13 Missed
Mar. 31 2023 -0.10 -0.11 Missed